Abbott Laboratories (NYSE:ABT) reported its Q3 2024 earnings, meeting EPS expectations while slightly missing revenue forecasts. The company posted an EPS of $1.34, aligning with analysts' predictions ...
Good day, and thank you for standing by. Welcome to the Capital One Q4 2024 earnings call. Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand ...
Management expects 2024 fourth quarter revenue of approximately $3.0 million and full year 2024 of approximately $8.6 million, representing growth year-over-year of over 100% for the third consecutive ...